PD-1 and PD-L1 Expression in Peripheral CD4/CD8+ T Cells Is Restored in the Partial Remission Phase in Type 1 Diabetes

PD-1 and PD-L1 Expression in Peripheral CD4/CD8+ T Cells Is Restored in the Partial Remission Phase in Type 1 Diabetes

(2020) Xia Li et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Partial remission and early stages of pediatric type 1 diabetes display immunoregulatory changes. A pilot study

(2019) Adrian Villalba et al.   Translational Research

Remission phase in children diagnosed with type 1 diabetes in years 2012 to 2013 in Silesia, Poland: An observational study

(2019) Agata Chobot et al.   PEDIATRIC DIABETES

Biomarker discovery in pre-Type 1 Diabetes; Th40 cells as a predictive risk factor

(2019) Gisela M Vaitaitis et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Successful Treatment of Immune Checkpoint Inhibitor–Induced Diabetes Mellitus With Infliximab

(2019) Beckey Trinh et al.   DIABETES CARE

The remission phase in type 1 diabetes: changing epidemiology, definitions and emerging immuno‐metabolic mechanisms

(2019) Ting Zhong et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

B lymphocytes expressing high levels of PD-L1 are key regulators of diabetes development in non-obese diabetic mice

(2019) Kun Chen et al.   MOLECULAR IMMUNOLOGY

Genetic and epigenetic influences on the loss of tolerance in autoimmunity

(2018) Peng Zhang et al.   Cellular & Molecular Immunology

Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhibitors

(2018) Angeliki M. Stamatouli et al.   DIABETES

Immune cell and cytokine patterns in children with type 1 diabetes mellitus undergoing a remission phase: A longitudinal study

(2018) Ana Laura Fitas et al.   PEDIATRIC DIABETES

Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens

(2018) Romualdo Barroso-Sousa et al.   JAMA Oncology

Type 1 Diabetes in Children and Adolescents: A Position Statement by the American Diabetes Association

(2018) Jane L. Chiang et al.   DIABETES CARE

Targeting Programmed Cell Death -1 (PD-1) and Ligand (PD-L1): A new era in cancer active immunotherapy

(2018) Anastasia Constantinidou et al.   PHARMACOLOGY & THERAPEUTICS

PDL1 is expressed in the islets of people with type 1 diabetes and is up-regulated by interferons-α and-γ via IRF1 induction

(2018) Maikel L. Colli et al.   EBioMedicine

Identification of autoimmune type 1 diabetes and multiple organ-specific autoantibodies in adult-onset non-insulin-requiring diabetes in China: A population-based multicentre nationwide survey

(2018) Yufei Xiang et al.   DIABETES OBESITY & METABOLISM

Tetraspanin 7 autoantibodies predict progressive decline of beta cell function in individuals with LADA

(2018) Xiajie Shi et al.   DIABETOLOGIA

The challenge of modulating β-cell autoimmunity in type 1 diabetes

(2018) Mark A Atkinson et al.   Lancet Diabetes & Endocrinology

Programmed cell death-1, PD-1, is dysregulated in T cells from children with new onset type 1 diabetes

(2017) Hector M. Granados et al.   PLoS One

Persistence of glutamic acid decarboxylase antibody (GADA) is associated with clinical characteristics of latent autoimmune diabetes in adults: a prospective study with 3-year follow-up

(2016) Gan Huang et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Low programmed cell death-1 (PD-1) expression in peripheral CD4+T cells in Japanese patients with autoimmune type 1 diabetes

(2015) R. Fujisawa et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

PD-1-dependent restoration of self-tolerance in the NOD mouse model of diabetes after transient anti-TCRβ mAb therapy

(2015) Paul M. Schroder et al.   DIABETOLOGIA

Expression of PD-1 Molecule on Regulatory T Lymphocytes in Patients with Insulin-Dependent Diabetes Mellitus

(2015) Valentina Perri et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Influence of remission and its duration on development of early microvascular complications in young adults with type 1 diabetes

(2015) Pawel Niedzwiecki et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Anti-IL-7 receptor-  reverses established type 1 diabetes in nonobese diabetic mice by modulating effector T-cell function

(2012) L.-F. Lee et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

New Definition for the Partial Remission Period in Children and Adolescents With Type 1 Diabetes

(2009) H. B. Mortensen et al.   DIABETES CARE